Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-09-11
DOI
10.3389/fimmu.2018.02080
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of hepatitis B virus replication via HBV DNA cleavage by Cas9 from Staphylococcus aureus
- (2018) Yu Liu et al. ANTIVIRAL RESEARCH
- Mapping the genomic landscape of CRISPR–Cas9 cleavage
- (2017) Peter Cameron et al. NATURE METHODS
- CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR–Cas9 nuclease off-targets
- (2017) Shengdar Q Tsai et al. NATURE METHODS
- In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
- (2017) Eunji Kim et al. Nature Communications
- Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens
- (2017) David W. Morgens et al. Nature Communications
- Removal of Integrated Hepatitis B Virus DNA Using CRISPR-Cas9
- (2017) Hao Li et al. Frontiers in Cellular and Infection Microbiology
- ssAAVs containing cassettes encoding SaCas9 and guides targeting hepatitis B virus inactivate replication of the virus in cultured cells
- (2017) Tristan Scott et al. Scientific Reports
- Genome editing with CRISPR/Cas9 in postnatal mice corrects PRKAG2 cardiac syndrome
- (2016) Chang Xie et al. CELL RESEARCH
- Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study
- (2016) R Kaminski et al. GENE THERAPY
- An Effective Molecular Target Site in Hepatitis B Virus S Gene for Cas9 Cleavage and Mutational Inactivation
- (2016) Hao Li et al. International Journal of Biological Sciences
- Progress With Developing Use of Gene Editing To Cure Chronic Infection With Hepatitis B Virus
- (2016) Abdullah Ely et al. MOLECULAR THERAPY
- A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice
- (2016) Yang Yang et al. NATURE BIOTECHNOLOGY
- Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
- (2016) Hao Yin et al. NATURE BIOTECHNOLOGY
- Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication
- (2015) Chunsheng Dong et al. ANTIVIRAL RESEARCH
- Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated Cas9 system to disrupt the hepatitis B virus
- (2015) S Zhen et al. GENE THERAPY
- Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome
- (2015) Xing Liu et al. JOURNAL OF GENERAL VIROLOGY
- Measuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9
- (2015) Taeyoung Koo et al. MOLECULES AND CELLS
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- A genome-wide analysis of Cas9 binding specificity using ChIP-seq and targeted sequence capture
- (2015) Henriette O'Geen et al. NUCLEIC ACIDS RESEARCH
- In vivo gene editing in dystrophic mouse muscle and muscle stem cells
- (2015) M. Tabebordbar et al. SCIENCE
- Dual gRNAs guided CRISPR/Cas9 system inhibits hepatitis B virus replication
- (2015) Jie Wang WORLD JOURNAL OF GASTROENTEROLOGY
- CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling
- (2014) Randall J. Platt et al. CELL
- Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins
- (2014) S. Kim et al. GENOME RESEARCH
- In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9
- (2014) Lukasz Swiech et al. NATURE BIOTECHNOLOGY
- Targeting Hepatitis B Virus With CRISPR/Cas9
- (2014) Christoph Seeger et al. Molecular Therapy-Nucleic Acids
- Hepatocyte-targeted RNAi Therapeutics for the Treatment of Chronic Hepatitis B Virus Infection
- (2013) Christine I Wooddell et al. MOLECULAR THERAPY
- Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma
- (2012) Wing-Kin Sung et al. NATURE GENETICS
- Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
- (2010) E. Jenny Heathcote et al. GASTROENTEROLOGY
- Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B*
- (2009) R. G. Gish et al. JOURNAL OF VIRAL HEPATITIS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started